Managing the unpredictable symptoms of indolent systemic mastocytosis prompted a search for answers and community.
An 84-year-old man left clinicians at a Hong Kong hospital utterly perplexed after arriving at the hospital to be treated […] ...
Argyria is caused by a buildup of silver in the body, which discolors the skin.
Epidermolysis Bullosa (EB), or butterfly disease, affects 1 in 50,000 people, causing fragile skin that blisters easily, ...
Researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants.
Quoin Pharmaceuticals, a biotech company with a keen focus on rare diseases, has recently been making waves in the world of dermatology with its treatment for Netherton Syndrome. This rare genetic ...
Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.
Sanofi and Regeneron's Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitating skin ...
A common antihistamine may offer hope for patients with a rare genetic disease that can lead to severe liver damage and ...